Biochips Market to Grow from USD 14.01 Billion in 2025 to USD 21.36 Billion by 2030, at a CAGR of 8.8% - MarketsandMarkets™

Delray Beach, FL , Aug. 18, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global biochips market to reach USD 21.36 billion by 2030 from USD 14.01 billion in 2025, growing at a CAGR of 8.8% during the forecast period. Market growth is driven by increasing demand for personalized medicine and the rising focus on precision diagnostics. The growing prevalence of chronic and infectious diseases, expanding applications in drug discovery, genomics, and proteomics, and increasing emphasis on non-invasive diagnostic techniques such as liquid biopsy are supporting broader adoption of biochip technologies.

Get PDF Brochure - Market Data & Segmentation:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54

Key Market Highlights

• Market size, 2025: USD 14.01 billion
• Market forecast, 2030: USD 21.36 billion
• Growth rate: CAGR of 8.8% (2025–2030)
• Major growth drivers: Personalized medicine, precision diagnostics, and expanding applications in drug discovery, genomics, and proteomics
• Key enabling technologies: Artificial intelligence, machine learning, and microfluidics
• Key players: Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), and QIAGEN (Germany)

Why This Market Matters

Biochips are gaining importance as healthcare and life sciences organizations seek high-throughput, precise, and efficient approaches to biological analysis. Growing demand for personalized medicine and precision diagnostics is increasing the use of biochip technologies across genomics, proteomics, drug discovery, and clinical applications. The rising prevalence of chronic and infectious diseases, combined with the growing need for non-invasive diagnostics and point-of-care testing, is further supporting market expansion.

Market Overview

The biochips market is expanding as advanced bioanalytical technologies become increasingly integrated into clinical research and healthcare workflows. High-throughput screening requirements across clinical and research settings are supporting adoption, while the integration of AI, machine learning, and microfluidics is enabling product innovation and improved efficiency. Research collaborations between academia and industry, along with increasing penetration of e-commerce distribution channels, are also enhancing access to biochip technologies, particularly in emerging markets.

Analyst Perspective

The biochips industry is moving toward more integrated, high-throughput, and data-driven analytical workflows. The convergence of biochip platforms with AI, machine learning, microfluidics, genomics, and advanced bioinformatics is creating opportunities for more efficient biological analysis and precision healthcare applications. Companies that strengthen their product portfolios through new product introductions, strategic partnerships, and expansion into emerging markets are expected to improve their competitive positioning.

Speak to Our Analyst - Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=54

Segment Analysis

The biochips market is supported by expanding applications across personalized medicine, precision diagnostics, drug discovery, genomics, and proteomics. The growing need for high-throughput screening in clinical and research settings is increasing demand for technologies that can process biological information efficiently and accurately.

The market is also benefiting from the increasing emphasis on non-invasive diagnostic techniques, including liquid biopsy, and the rising demand for point-of-care diagnostics. These applications are broadening the role of biochip technologies beyond research environments and into clinical and decentralized testing settings.

Regional Analysis

The attached Article 1 identifies expanding adoption in emerging markets, supported by research collaborations between academia and industry and increasing penetration of e-commerce distribution channels. These factors are improving accessibility to biochip technologies and supporting market adoption. The provided source materials do not specify a single largest regional market or a regional CAGR, so no unsupported regional ranking is included in this release.

Key Industry Trends

• Increasing demand for personalized medicine and precision diagnostics
• Growing applications of biochips in drug discovery, genomics, and proteomics
• Rising emphasis on non-invasive diagnostics such as liquid biopsy
• Increasing demand for high-throughput screening
• Integration of artificial intelligence and machine learning into biochip applications
• Growing use of microfluidics to improve biochip efficiency and functionality
• Rising demand for point-of-care diagnostics
• Expansion of academia-industry research collaborations
• Increasing penetration of e-commerce distribution channels in emerging markets

Competitive Landscape

The competitive landscape of the biochips market is led by established global companies including Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), and QIAGEN (Germany), among other market participants. These companies are pursuing organic and inorganic growth strategies, including new product introductions, strategic partnerships, and expansion into emerging markets.

Thermo Fisher Scientific Inc. is advancing its position by enhancing microarray technologies and bioinformatics solutions supporting genomics, diagnostics, and drug discovery. Its broader portfolio includes scientific instrumentation, reagents, consumables, software, and services across healthcare, life sciences, academia, government, and biotechnology.

Illumina, Inc. is a leading genomics and life sciences company with integrated systems for analyzing genetic variation and biological function. Its portfolio includes next-generation sequencing instruments, array-based genotyping systems, library preparation kits, sequencing reagents, consumables, and software and analytics solutions. Its technologies support applications including oncology, reproductive health, infectious disease, agriculture, and population genomics.

Agilent Technologies, Inc. is expanding its offerings in genomic profiling and molecular diagnostics, with a focus on cancer diagnostics and precision medicine through advanced analytical tools. F. Hoffmann-La Roche Ltd is strengthening its molecular diagnostics portfolio, particularly in oncology and genetic testing technologies, while QIAGEN focuses on molecular testing and genetic analysis to support precision medicine and oncology diagnostics.

Related Reports

Next-generation Sequencing Market
Genomics Market

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/